Exploring Complement Biology to Improve Antibody-based Therapies for Non-Hodgkin Lymphoma

Rogers lab_blog

Among the many types of cancer acknowledged during the month of September is lymphoma, a cancer arising from a subset of white blood cells (lymphocytes) that compose an important part …

Read More

New Combination Chemotherapy for Colorectal Cancer


Last week, the U.S. Food and Drug Administration (FDA) approved a new combination of drugs, formulated together in a single pill called Lonsurf (previously known as TAS-102), to treat patients with advanced colorectal cancer that is no longer responding to other treatments after the treatment was shown in a double-blind, placebo-controlled, phase III clinical trial to extend overall survival.

Read More

Federally Funded Research Can Power Progress Against Cancer

CPR15 cover for blog

Today, the American Association for Cancer Research (AACR) released the results of a national survey on American voter’s opinions about cancer and cancer research funding in conjunction with its fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to prioritize the growth of the budgets of the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA).

Read More